{"id":3824,"date":"2019-06-03T05:46:42","date_gmt":"2019-06-03T03:46:42","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/lovande-resultat-med-pharmashell-belagt-protein\/"},"modified":"2020-06-26T14:14:24","modified_gmt":"2020-06-26T12:14:24","slug":"lovande-resultat-med-pharmashell-belagt-protein","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/lovande-resultat-med-pharmashell-belagt-protein\/","title":{"rendered":"Lovande resultat med PharmaShell\u00ae-belagt protein"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><span><strong><\/strong><\/span><\/p>\n<\/div>\n<p><span>Nanexa har genomf\u00f6rt f\u00f6rs\u00f6k d\u00e4r ett aktivt protein belagts med PharmaShell\u00ae-skal. I f\u00f6rs\u00f6ken som utf\u00f6rdes p\u00e5 Nanexas utvecklingslaboratorium i Uppsala ser vi att vi som v\u00e4ntat erh\u00e5ller en l\u00e5ngsam och kontrollerad fris\u00e4ttning av proteinet. Vi har ocks\u00e5 visat att det PharmaShell\u00ae-belagda proteinet bibeh\u00e5ller sin biologiska aktivitet efter att det g\u00e5tt igenom tillverkningsprocessen, vilket \u00e4r n\u00e5got som \u00e4r avg\u00f6rande f\u00f6r att kunna utveckla l\u00e5ngtidsverkande proteinbaserade l\u00e4kemedel.<\/span><\/p>\n<p><span>M\u00e5nga nya l\u00e4kemedel baseras p\u00e5 proteiner som har en specifik behandlande aktivitet f\u00f6r en viss sjukdom. Det \u00e4r i m\u00e5nga fall avg\u00f6rande att bibeh\u00e5lla den aktiviteten under en l\u00e4ngre tid f\u00f6r att f\u00e5 b\u00e4sta effekt av proteinet. Vi har nu visat att det kan m\u00f6jligg\u00f6ras med hj\u00e4lp av en PharmaShell\u00ae- baserad dep\u00e5beredning som fris\u00e4tter nytt protein under en l\u00e4ngre tid. De nya resultaten st\u00e4rker v\u00e5r position och tillf\u00f6r ytterligare information som visar att PharmaShell\u00ae\u00a0kan vara ett mycket konkurrenskraftigt verktyg f\u00f6r att skapa s\u00e5dana l\u00e4kemedel.<\/span><\/p>\n<p><span>Nanexas VD David Westberg kommenterar:<\/span><\/p>\n<p><span>Behovet av bra drug delivery-teknologier f\u00f6r att skapa l\u00e5ngtidsverkande peptid- och proteinl\u00e4kemedel \u00e4r stort. Ut\u00f6ver de resultat som omn\u00e4mnts ovan m\u00f6jligg\u00f6r PharmaShell\u00ae- skapandet av ett l\u00e4kemedel med h\u00f6g s\u00e5 kallad drug load. Min bed\u00f6mning \u00e4r att dessa resultat kommer vara mycket intressanta f\u00f6r bolag som utvecklar proteinbaserade l\u00e4kemedel.<\/span><\/p>\n<p><span>F\u00f6r mer information kontakta:<br \/>David Westberg\u00a0\u2013\u00a0VD, Nanexa AB (publ)\u00a0Telefon: 0709-42 83 03<br \/>E-post: david.westberg@nanexa.se www.nanexa.com<\/span><\/p>\n<p><span>Om Nanexa AB (publ)<br \/>Nanexa AB \u00e4r ett nanoteknologiskt drug deliveryf\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av PharmaShell\u00ae\u00a0som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae\u00a0har Nanexa samarbetsavtal med bland andra AstraZeneca.<\/span><\/p>\n<p><\/p>\n<p><span><strong><\/strong><\/span><\/p>\n<p><\/p>\n<p><span><strong><\/strong><\/span><\/p>\n<div class=\"mfn-footer mfn-attachment\">\n<p><strong>Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a href=\"https:\/\/mb.cision.com\/Main\/12591\/2830628\/1055911.pdf\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Read as PDF<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<\/p>\n<p>Nanexa har genomf\u00f6rt f\u00f6rs\u00f6k d\u00e4r ett aktivt protein belagts med PharmaShell\u00ae-skal. I f\u00f6rs\u00f6ken som utf\u00f6rdes p\u00e5 Nanexas utvecklingslaboratorium i Uppsala ser vi att vi som v\u00e4ntat erh\u00e5ller en l\u00e5ngsam och kontrollerad fris\u00e4ttning av proteinet.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/mfn_news\/lovande-resultat-med-pharmashell-belagt-protein\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"template":"","class_list":["post-3824","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lovande resultat med PharmaShell\u00ae-belagt protein - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/lovande-resultat-med-pharmashell-belagt-protein\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lovande resultat med PharmaShell\u00ae-belagt protein - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexa har genomf\u00f6rt f\u00f6rs\u00f6k d\u00e4r ett aktivt protein belagts med PharmaShell\u00ae-skal. I f\u00f6rs\u00f6ken som utf\u00f6rdes p\u00e5 Nanexas utvecklingslaboratorium i Uppsala ser vi att vi som v\u00e4ntat erh\u00e5ller en l\u00e5ngsam och kontrollerad fris\u00e4ttning av proteinet.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/lovande-resultat-med-pharmashell-belagt-protein\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:modified_time\" content=\"2020-06-26T12:14:24+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/lovande-resultat-med-pharmashell-belagt-protein\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/lovande-resultat-med-pharmashell-belagt-protein\\\/\",\"name\":\"Lovande resultat med PharmaShell\u00ae-belagt protein - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2019-06-03T03:46:42+00:00\",\"dateModified\":\"2020-06-26T12:14:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/lovande-resultat-med-pharmashell-belagt-protein\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/lovande-resultat-med-pharmashell-belagt-protein\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/lovande-resultat-med-pharmashell-belagt-protein\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Lovande resultat med PharmaShell\u00ae-belagt protein\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lovande resultat med PharmaShell\u00ae-belagt protein - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/lovande-resultat-med-pharmashell-belagt-protein\/","og_locale":"sv_SE","og_type":"article","og_title":"Lovande resultat med PharmaShell\u00ae-belagt protein - Nanexa AB","og_description":"Nanexa har genomf\u00f6rt f\u00f6rs\u00f6k d\u00e4r ett aktivt protein belagts med PharmaShell\u00ae-skal. I f\u00f6rs\u00f6ken som utf\u00f6rdes p\u00e5 Nanexas utvecklingslaboratorium i Uppsala ser vi att vi som v\u00e4ntat erh\u00e5ller en l\u00e5ngsam och kontrollerad fris\u00e4ttning av proteinet.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/mfn_news\/lovande-resultat-med-pharmashell-belagt-protein\/","og_site_name":"Nanexa AB","article_modified_time":"2020-06-26T12:14:24+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/lovande-resultat-med-pharmashell-belagt-protein\/","url":"https:\/\/nanexa.com\/mfn_news\/lovande-resultat-med-pharmashell-belagt-protein\/","name":"Lovande resultat med PharmaShell\u00ae-belagt protein - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2019-06-03T03:46:42+00:00","dateModified":"2020-06-26T12:14:24+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/lovande-resultat-med-pharmashell-belagt-protein\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/lovande-resultat-med-pharmashell-belagt-protein\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/lovande-resultat-med-pharmashell-belagt-protein\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Lovande resultat med PharmaShell\u00ae-belagt protein"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3824","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=3824"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}